Patent ID: 6482589
Filing Date: 2002-11-19
Classification: C12Q,Y10S

Abstract:
A composition consisting of nucleic acids containing 10 to 250 nucleotides which hybridize under identical conditions to rRNA or rDNA of pathogenic Mycoplasma genitalium bacteria and not to rRNA or rDNA of nonmycoplasma bacteria in humans wherein the nucleic acids are complementary or homologous to a sequence comprising any ten consecutive nucleotides with a nucleic acid sequence selected from the group consisting of sequences 2262 (SEQ ID NO: 1), 2256 (SEQ ID NO: 2), 2246 (SEQ ID NO: 3), 2218 (SEQ ID NO: 4), 2271 (SEQ ID NO: 5), 2220 (SEQ ID NO: 6), 2259 (SEQ ID NO: 7), 2227 (SEQ ID NO: 8), 2335 (SEQ ID NO: 10), 2337 (SEQ ID NO: 11), 2334 (SEQ ID NO: 12), 2336 (SEQ ID NO: 13), 2191 (SEQ ID NO: 14), 2228 (SEQ ID NO: 15), and 2260 (SEQ ID NO: 16) and (2) complementary or homologous with at least one region of rRNA or rDNA selected from the group of regions consisting of positions 1110 to 1160 of the Mycoplasma genitalium 16S rRNA, and positions 260 to 330, 1590 to 1630, and 1850 to 1900 of Mycoplasma genitalium 23S rRNA, and such numerical designations are nucleotide positions counted from the 5â€² end of the RNA molecule.